- Home
- SNDL vs DNTH Comparison
SNDL vs DNTH Comparison
Compare SNDL & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDL
- DNTH
- Stock Information
- Founded
- SNDL 2006
- DNTH 2015
- Country
- SNDL Canada
- DNTH United States
- Employees
- SNDL 2604
- DNTH N/A
- Industry
- SNDL Pharmaceuticals and Biotechnology
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- SNDL Health Care
- DNTH Health Care
- Exchange
- SNDL Nasdaq
- DNTH Nasdaq
- Market Cap
- SNDL 638.2M
- DNTH 780.2M
- IPO Year
- SNDL 2019
- DNTH N/A
- Fundamental
- Price
- SNDL $2.48
- DNTH $26.50
- Analyst Decision
- SNDL Strong Buy
- DNTH Strong Buy
- Analyst Count
- SNDL 1
- DNTH 8
- Target Price
- SNDL $5.00
- DNTH $54.00
- AVG Volume (30 Days)
- SNDL 5.2M
- DNTH 374.5K
- Earning Date
- SNDL 11-04-2025
- DNTH 11-06-2025
- Dividend Yield
- SNDL N/A
- DNTH N/A
- EPS Growth
- SNDL N/A
- DNTH N/A
- EPS
- SNDL N/A
- DNTH N/A
- Revenue
- SNDL $692,339,389.00
- DNTH $4,854,000.00
- Revenue This Year
- SNDL $5.52
- DNTH N/A
- Revenue Next Year
- SNDL $4.09
- DNTH N/A
- P/E Ratio
- SNDL N/A
- DNTH N/A
- Revenue Growth
- SNDL 3.54
- DNTH 17.87
- 52 Week Low
- SNDL $1.15
- DNTH $13.37
- 52 Week High
- SNDL $2.74
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- SNDL 65.18
- DNTH 70.68
- Support Level
- SNDL $2.37
- DNTH $22.81
- Resistance Level
- SNDL $2.62
- DNTH $24.81
- Average True Range (ATR)
- SNDL 0.14
- DNTH 1.57
- MACD
- SNDL -0.01
- DNTH 0.22
- Stochastic Oscillator
- SNDL 63.38
- DNTH 91.57
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.